Molecular Biology Reports

, Volume 37, Issue 5, pp 2397–2402 | Cite as

Role of dephosphorylation of FOXO1 on apoptosis induced by wortmannin for non-Hodgkin’s lymphoma cells

  • Zhan Qiong
  • Huang Ruofan
  • Liang Xiaohua
  • Zhou Xinli
  • Jiang Jingwei
  • Chu Zhaohui
Article
First Online:
Received:
Accepted:

Abstract

The aim of this study was to ascertain the relationship between the phosphorylation of FOXO1 and the apoptosis and the proliferation of lymphoma cells so as to further clarify the cellular biology and pathogenesis of the disease. The lymphoma cells Namalwa and Jurkat were treated with PI3K inhibitor wortmannin or etoposide alone or wortmannin plus etoposide with different schedule. The inhibition rates of lymphoma cell growth were examined by XTT assay. Apoptosis were detected by flow cytometry. The expression of p-Akt, p-FOXO1, FOXO1, bim were determined by western blot analysis. Wortmannin induced apoptosis of Jurkat cells and Namalwa cells and inhibited their survival effectively. The rate of growth inhibition and apoptosis of lymphoma cells induced by wortmannin plus etoposide were higher than those induced by etoposide alone. After treated with wortmannin, phosphorylation of FOXO1 remarkably reduced and bim increased. The dephosphorylation of FOXO1 inhibited proliferation of Jurkat cells and Namalwa cells, promoted their apoptosis and sensitized Non-Hodgkin lymphoma cells to etoposide. Bim activated by FOXO1 promoted cells apoptosis.

Keywords

Lymphoma Non-Hodgkin FOXO1 protein Human Bim PI3K/Akt pathway Apoptosis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Roeb W, Boyer A, Cavenee WK, Arden KC (2008) Guilt by association: PAX3-FOXO1 regulates gene expression through selective destabilization of the EGR1 transcription factor. Cell Cycle 7:837–841PubMedGoogle Scholar
  2. 2.
    Xia SJ, Barr FG (2005) Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur J Cancer 41:2513–2527PubMedGoogle Scholar
  3. 3.
    Paik JH, Kollipara R, Chu G et al (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309–323CrossRefPubMedGoogle Scholar
  4. 4.
    Ciechomska I, Pyrzynska B, Kazmierczak P, Kaminska B (2003) Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene 22:7617–7627CrossRefPubMedGoogle Scholar
  5. 5.
    Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dörken B, Bargou RC (2004) PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 18:1883–1890CrossRefPubMedGoogle Scholar
  6. 6.
    Sourbier C, Lindner V, Lang H et al (2006) The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res 66:5130–5142CrossRefPubMedGoogle Scholar
  7. 7.
    Amstutz R, Wachtel M, Troxler H et al (2008) Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities. Cancer Res 68:3767–3776CrossRefPubMedGoogle Scholar
  8. 8.
    Burgering BMT, Medema RH (2003) Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. Leukoc Biol 75:1–13CrossRefGoogle Scholar
  9. 9.
    Lynch DK, Ellis CA, Edwards PA, Hiles ID (1999) Integrin-linked kinase regulates phosphorylation of serine473 of protein kinase B by an indirect mechanism. Oncogene 18:8024–8032CrossRefPubMedGoogle Scholar
  10. 10.
    Jia L, Yu W, Wang P, Sanders BG, Kline K (2008) In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostat 68:849–860CrossRefGoogle Scholar
  11. 11.
    Adachi M, Osawa Y, Uchinami H, Kitamura T, Accili D, Brenner DA (2007) The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology 132:1434–1446CrossRefPubMedGoogle Scholar
  12. 12.
    Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, Yang (2008) PP2A regulates the pro-apoptotic activity of FOXO1. Biol Chem 283:7411–7420CrossRefGoogle Scholar
  13. 13.
    Villunger A, Scott C, Bouillet P, Strasser A (2003) Essential role for the BH3-only protein Bim, but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 101:2393–2400CrossRefPubMedGoogle Scholar
  14. 14.
    Bauer A, Kirschnek S, Häcker G (2007) Inhibition of apoptosis can be accompanied by increased Bim levels in T lymphocytes and neutrophil granulocytes. Cell Death Differ 14:1714–1716CrossRefPubMedGoogle Scholar
  15. 15.
    Chen D, Zhou Q (2004) Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc Natl Acad Sci USA 101:1235–1240CrossRefPubMedGoogle Scholar
  16. 16.
    Liu JW, Chandra D, Tang SH, Chopra D, Tang DG (2002) Identification and characterization of Bim γ, a novel proapoptotic BH3-only splice variant of Bim. Cancer Res 62:2976–2981PubMedGoogle Scholar
  17. 17.
    Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162:613–622CrossRefPubMedGoogle Scholar
  18. 18.
    Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM, Medema RH (2002) The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 168:5024–5031PubMedGoogle Scholar
  19. 19.
    Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10:1201–1204CrossRefPubMedGoogle Scholar
  20. 20.
    Rahmani M, Yu C, Reese E, Ahmed W, Hirsch K, Dent P, Grant S (2003) Inhibition of PI-3 kinases ensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42MAP kinasein activation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. Oncogene 22:6231–6242CrossRefPubMedGoogle Scholar
  21. 21.
    Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S (2003) The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl + cells sensitive and resistant to STI571. Blood 102:3765–3774CrossRefPubMedGoogle Scholar
  22. 22.
    Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S (2008) Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res 68:6271–6280CrossRefPubMedGoogle Scholar
  23. 23.
    Liu SQ, Yu JP, Yu HG, Lv P, Chen HL (2006) Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Dig Liver Dis 38:310–318CrossRefPubMedGoogle Scholar
  24. 24.
    Liu P, Kao TP, Huang H (2008) CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27:4733–4744CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Zhan Qiong
    • 1
  • Huang Ruofan
    • 1
  • Liang Xiaohua
    • 1
  • Zhou Xinli
    • 1
  • Jiang Jingwei
    • 1
  • Chu Zhaohui
    • 1
  1. 1.Department of OncologyHuashan Hospital, Fudan UniversityShanghaiPeople’s Republic of China

Personalised recommendations